Harry LamEVP Technical Operations at JW Therapeutics (Shanghai) Co., LTD., China
Dr. Harry Lam is currently EVP, Technical Operations at JW Therapeutics. Previously, he was VP, Biologics Manufacturing at Sanofi; and VP, Manufacturing and Technical Operations, Progenitor Cell Therapy (PCT), A Subsidiary of Hitachi Chemical Advanced Therapeutics Solutions.
Dr. Lam also spent 17 years at Genentech, where he held a variety of positions with increasing responsibilities, including Director of Manufacturing & Technology, Genentech Singapore Pte Ltd; Senior Director, Global Head of Biologics Drug Substance Manufacturing Science & Technology; and Roche Global Head of Contract Manufacturing Operations, Commercial Drug Substance.
Harry received his B.S. in Chemical Engineering from the University of Birmingham, UK and his Ph.D. in Chemical Engineering from Rensselaer Polytechnic Institute, NY.